Pharmaceutical company Darnitsa

Darnitsa is the national producer of medicines. Cardiology, neurology, and pain syndrome are among its strategic priorities.
Company website: http://www.darnitsa.ua

Company authors Pharmaceutical company Darnitsa

Glib Zagorij
Glib Zagorij
beneficiary of the Pharmaceutical company Darnitsa

About Pharmaceutical company Darnitsa

The company has come a long way from a Soviet enterprise to a modern hi-tech pharmaceutical plant. Over the past decade, Darnitsa modernized all its core and ancillary manufacturing facilities, built a robotic warehouse complex for 10,000 pallet positions, invested over €200 million in production, implemented an automated manufacturing planning system, and obtained a GMP certificate.

Such an approach allowed Darnitsa to take the lead among national pharmaceutical producers and become number one in the sales of prepackaged medications in Ukraine.

Structure of ownership Pharmaceutical company Darnitsa

Beneficiary: Hlib Zagoriy
Chairman, Executive Board of the Managing Company: Dmytro Shymkiv
CEO: Andriy Obrizan

Essence of business Pharmaceutical company Darnitsa

Annually, Darnitsa produces 4.2 billion pills and capsules; 460 million ampoules; 50 million tubes of semi-solid dosage forms; 40 million vials of drops; 30 million vials of powders for injection; 15 million vials of solutions for infusions.
This project uses cookies from Mind to deliver its services and to analyze traffic.Learn moreOK, Got it